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Background: The leaves of Stachytarpheta cayennensis C. Rich. (Verbenaceae) have been reported to possess potent
anti-inflammatory and anti-malarial activities. Due to close association between inflammatory and immune responses,
we evaluated the immunomodulatory activity of leaves extract of S. cayennensis. The combined effects of the leaves
extract and artesunate, a standard antimalarial agent with immunomodulatory effects, were also evaluated.
Methods: The immunomodulatory activity of the methanol extract of the leaves of S. cayennensis (MESC) was
evaluated in mice using the Delayed-Type hypersensitivity response (DTHR), primary and secondary humoral immune
responses and the in vivo leucocyte mobilization tests. The immunomodulatory effect of artesunate and the combined
effects of MESC and artesunate were evaluated using the phagocytic activity of polymorphonuclear neutrophils. Acute
toxicity and lethality test in addition to the preliminary phytochemical studies of MESC were also performed.
Results: The MESC exhibited 64.21% inhibition of DTHR at 500 mg/kg dose and evoked 139.64% of phagocytic
stimulation at 100 μg/ml dose. Also MESC significantly (p < 0.05) showed dose related stimulation of humoral immunity
and a highest percentage leucocyte mobilization of 10.15% at 250 mg/kg dose. Artesunate offered a non-significant
(p > 0.05) percentage phagocytic stimulation (PPS) while the combined effect of artesunate and MESC exhibited a
significant (p < 0.05) dose dependent PPS with highest PPS of 393.77% at 100 μg/ml. The LD50 of the MESC was
estimated to be greater than 5000 mg/kg since there were no lethality and signs of acute intoxication after 48 h
observation. Preliminary phytochemical analysis revealed the presence of carbohydrates, glycosides, flavonoids,
saponins, alkaloids, terpenoids and steroids.
Conclusions: The results of this study indicated that MESC possesses immunostimulatory action with significant
synergistic effects with artesunate, and can therefore, offer immune boosting activities in disorders of immune
suppression.
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The scourge of acquired immune deficiency syndrome
(AIDS) and other related immune deficiency diseases such
as ebola virus disease and tuberculosis, especially in the
developing countries, are established health concerns. In
most cases, the suppression of immune system not only
attracts opportunistic infections but also adversely affects
the quality of life of patients. These, together with the at-
tendant co-morbidity of immune disorders have recently
stimulated research interest in the area of immune boost-
ing potentials of medicinal plants.
The human immune system consists of two categories
of defense mechanisms; the innate (non-specific) and
the adaptive (specific) systems. These two mechanisms
could be modified by substances, such as drugs and
plant constituents, to either enhance or suppress their
ability to resist invasion by pathogens [1,2]. The concern
about the safety and adverse effects of the conventional
immunomodulatory synthetic drugs has led to a growing
interest in identifying and characterizing natural com-
pounds with immunomodulatory effects possessing low
profile toxicity [3,4].
Medicinal plants have been reported to possess nume-
rous secondary metabolites with potent immunomodula-
tory effects [3,5,6]. Most of these plants or plant parts are
being used in folkloric medicine by rural dwellers to boost
their immunity against infections. Studies have shown that
many plants with proven anti-inflammatory effect also
possess immunomodulatory effects based on the relation-
ship between physiological mechanisms of inflammation
and immune responses [7-9]. Some medicinal plants with
established immunomodulatory effects are Panax ginseng,
Viscum album, Tinospora cordifolia, Boerhaavia diffusa,
Withania somnifera, Ocimum sanctum and Curculigo
orchioides [10-15]. In addition, the immunomodulatory
effects of artesunate, an artemisinin derivative isolated
from the plant, Artemisia annua and related agents have
also been documented [16,17].
The leaves of Stachytarpheta cayennensis C. Rich
(Verbenaceae) have been documented to possess potent
analgesic, antimalarial and antiinflammatory effects
[18-20]. S. cayennensis, commonly known as “Gervâo” is
a weedy annual (and sometimes perennial) herbaceous
plant that grows mainly in the tropical rainforests, indi-
genous to most parts of tropical America, Mexico, Haiti,
West Indies and South America [21]. The plant is used
traditionally as anti-allergic, bronchodilatory, digestion-
stimulating, antacid and antidiarrhea [21], pain-relieving,
antispasmodic and antiinflammatory [22,20], liver protec-
tive and detoxification [23], cellular protective, antioxidant
and antimicrobial [22,24], anticonvulsant and sedative [25]
agents.
The present study investigated the immunomodulatory
potentials of methanol extract of S. cayennensis (MESC)leaves on cellular and humoral immune responses and
assessed its synergistic effect with artesunate, a standard
antimalarial agent with immunomodulatory potentials.
Methods
Collection and preparation of plant material
Fresh leaves of S. cayennensis were collected in the month
of July, from Nsukka, Enugu State, Nigeria. The plant was
identified and authenticated by Mr. Alfred Ozioko, a
taxonomist of the International Center for Ethnomedicine
and Drug Development (InterCEDD), Aku Road, Nsukka,
Enugu State, Nigeria. The voucher specimen was depo-
sited at the herbarium of the InterCEDD, Nsukka, Nigeria.
The leaves were cleaned, cut into small pieces, dried and
pulverized to coarse powder using a manual blender.
Extraction of plant material
The powdered dried leaves (700 g) were extracted with
methanol using cold maceration for 48 h. The entire bulk
was filtered and concentrated using rotary evaporator
under reduced pressure to obtain the methanol extract of
the leaves of S. cayennensis (MESC; 13.6% w/w) which
was subjected to various tests. The MESC before adminis-
tration was prepared by dissolving it in distilled water and
diluting to appropriate concentration in the course of each
experiment.
Materials
Pure artesunate sample (Emzor Pharma Nig. Ltd, Lagos)
and methanol extract of the leaves of S. cayennensis
(MESC).
Animals
Adult Swiss albino mice (22-30 g) and rat (200 g) of both
sexes were obtained from the Animal House Facility of
the Department of Pharmacology and Toxicology, Univer-
sity of Nigeria, Nsukka and used for this study. The ani-
mals were housed under standard conditions (25 ± 2°C)
with free access to standard pellets (Guinea Feed Nigeria,
Ltd.) and water. A healthy male sheep (for antigen used in
Delayed Type Hypersensitivity Reaction test) was taken
from the herd in the experimental animal facility of the
Faculty of Veterinary Medicine, University of Nigeria,
Nsukka. The sheep had free access to normal pasture in
the farm. The animals (mice and rat) were transferred to
the research area and were allowed a 14 day accli-
matization period before the experiments. All animal
experiments were conducted in compliance with the
National Institute of Health Guide for Care and Use of
Laboratory Animals (Pub No. 85-23, revised 1985) and in
accordance with the University of Nigeria Ethics Com-
mittee on the use of laboratory animals, registered by the
National Health Research Ethics Committee (NHREC)
of Nigeria, with the number; NHREC/05/01/2008B. The
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the University Ethics Committee.
Antigen
Fresh sheep blood (10 ml) was aseptically taken from
the jugular vein of a healthy male sheep and transferred
to heparinized tube. The blood samples were washed
thrice in about 5-10 ml of pyrogen-free sterile normal
saline by centrifugation at 3000 rpm for 10 min on each
occasion. The washed SRBCs was adjusted to a concen-
tration of 1 × 109 cells/ml with sterile normal saline and
used for immunization and challenge.
Micro-organism
Clinical isolates of Candida albicans obtained from the
Microbiology Unit of the Department of Pharmaceutics
and Pharmaceutical Microbiology, University of Nigeria,
Nsukka. The C. albicans had been isolated from a high
vaginal swab in the Medical Laboratory of a local hos-
pital at Nsukka, Nigeria.
Phytochemical analysis
Qualitative phytochemical analysis was performed on
MESC using standard procedures outlined by Harborne
[26] and Trease and Evans [27]. Briefly, frothing test for
saponins, Salkowski test for terpenoids, Liebermann-
Burchard tests for steroids, ferric chloride test for tannins,
Keller-Killiani test for cardiac glycosides, Dragendorff ’s
and Mayer’s test for alkaloids, Fehling’s test for reducing
sugars, xanthoproteic test for proteins, iodine test for
carbohydrates or starch and ammonia test for detection of
flavonoids were performed for qualitative identification of
the phytoconstituents present [28]. All reagents used for
the phytochemical analysis were freshly prepared.
Acute toxicity study
The acute lethal dose (LD50) of MESC was ascertained
by the method described by Lorke [29]. Briefly, the study
was performed in two phases. In the first phase, 9 mice
were divided into 3 groups of 3 mice per group, and
treated with the MESC at the doses of 10, 100 and
1000 mg/kg (p.o.) respectively. The animals were ob-
served for 24 h for signs of toxicity. In the second phase,
four mice were used. Three were treated separately with
MESC doses of 1600, 2900 and 5000 mg/kg respectively,
while the fourth (the control) received 10 ml/kg of dis-
tilled water. The animals were observed for 24 h period.
Preparation of Candida albicans suspension
Candida albicans culture was incubated in Sabouraud
dextrose broth overnight and centrifuged to form a cell
button at the bottom of the test tube. The supernatant
was discarded and the cell button was washed 3-4 times
with sterile phosphate buffer saline (PBS) and centrifuged.The washed cell button was re-suspended in a mixture of
PBS and rat serum in the proportion of 4:1. The count of
C. albicans was adjusted to 1 × 108 cells/ml using the 0.5
McFarland standard.
Preparation of the slide and evaluation of phagocytosis
About 0.2 ml of rat blood was smeared on sterile glass
slide and incubated at 37°C for 20 min for clotting to
occur. The slide was thereafter drained slowly with sterile
normal saline in order not to wash off the adhered neutro-
phils or polymorphonuclear (PMN) leucoccytes. The slide
consisting of neutrophils was flooded with the MESC,
artesunate and combinations of the MESC and artesunate
at different concentrations (25, 50 and 100 μg/ml), and
were incubated at 37°C for 20 min. The PMNs were
covered with C. albicans suspension and incubated at
37°C for 1 h. The slide was drained, fixed with methanol
and stained with Giemsa stain and observed (100 X)
under oil immersion and phagocytosis evaluated by the
method described by Ganachari et al. [30]. The number of
C. albicans cells phagocytosed by PMNs on the slide
was determined microscopically for granulocytes using
morphological criteria. This number was regarded as
Phagocytic Index (PI) and was compared with the PI of
the control treatment. Immunostimulation was calculated
using the following equation:
Percentage Phagocytic Stimulation ðPPSÞ ¼ PIðTestÞ  PI
ðControlÞ=PIðControlÞ  100:
Determination of Delayed Type Hypersensitivity Response
(DTHR)
Twenty mice were randomly divided into four groups
consisting of five animals per group. Delayed type hyper-
sensitivity was induced in mice using Sheep Red Blood
Cells (SRBCs). The MESC, suspended in distilled water,
was administered by oral gavage to the animals. Groups 1,
2 and 3 received 100, 250 and 500 mg/kg of the extract re-
spectively while group 4 received levamisole (control). On
day 0, one hour after extract administration, the rats were
sensitized by injecting 0.02 ml of 109 cells/ml of SRBCs
subcutaneously, into the right hind foot paw. The animals
were challenged on day 5 by subcutaneous injection of the
same amount of antigen (SRBCs) into the left hind foot
paw. The animals were treated with the extract 3 days
prior to sensitization and continued till the challenge. The
oedema produced by antigenic challenge in the left hind
paw was measured as the difference in the paw thickness
before and 24 h after the challenge. The paw thickness
was measured with a pocket-sized screw gauge [8,2,31].
Determination of humoral immune response
Twenty mice were randomly selected and divided into
four groups of five animals in each group. The MESC,
suspended in distilled water, was administered by oral
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250 and 500 mg/kg body weight of MESC respectively,
while group D (control) received distilled water. The
method of Nelson and Mildenhall [32] was used to de-
termine the effect of MESC on the antibody level of the
animals resulting from sensitization with SRBCs.
Briefly, on day zero, 0.1 ml of the 109 cell/ml SRBCs
was given by intra-peritoneal injection (i.p.) to all the
groups for immunization. The animals were challenged
on day 5 by similar i.p. injection of the same amount of
109 cell/ml SRBCs. The MESC was administered 3 days
prior to sensitization and continued daily for 5 days
after the challenge [2]. Primary antibody titre was deter-
mined on day 5 (before the challenge) and secondary
titre on day 10. Blood samples were obtained by retro-
orbital puncture into test tubes and allowed to clot. A
25 μl serum for each sample was obtained after cen-
trifugation and serially diluted two-fold in 96-U well
microtitre plates using pyrogen-free serial normal sa-
line. The last well on each row contained sterile normal
saline as control. The diluted sera were challenged with
25 μl of 1% v/v SRBCs in the plates and then incubated
at 37°C for 1 h. The highest dilution giving rise to vis-
ible heamagglutination was taken as antibody titre.
Antibody titres were expressed in graded manner, the
minimum dilution (1/2) being ranked as 1 (calculated






Flavonoids +In vivo leucocyte mobilization test
The method of Ribeiro et al. [33] was used in the test
for the effect of MESC on the in vivo leucocyte
mobilization induced by inflammatory stimulus. Mice
were divided into four groups of five animals each.
Groups I – III received MESC (100, 250 and 500 mg/kg,
respectively) while group IV received the vehicle. One
hour after the administration of the extract, each mice
in the groups received injection (i.p.) of 0.5 ml of 3% w/v
agar suspension in normal saline. Four hours later, the
mice were sacrificed and the peritoneum washed with
5 ml of a 5% solution of EDTA in Phosphate Buffered
Saline (PBS). Total and differential leucocyte counts
(TLC and DLC) were performed on the perfusates while
the percentage leucocyte mobilization (PLM) was calcu-
lated using the formula; PLM (%) = TLC (Test) – TLC






+ = present; - = absent.Statistical analysis
The results from the experiment were analyzed using
one way Analysis of variance (ANOVA; Dunnett post
hoc test) and expressed as the mean values for
each group ± SEM. The statistical significance between
the test and the control groups were considered at
p < 0.05.Results
Preliminary phytochemical analysis
Results of preliminary phytochemical analysis of the
MESC showed the presence of carbohydrates, glycosides,
flavonoids, saponins, alkaloids, terpenoids and steroids
(Table 1).
Acute toxicity and lethality test
The MESC exhibited an estimated LD50 greater than
5000 mg/kg (per oral) and did not cause any lethality
and signs of acute intoxication after 48 h observation
period. This was in line with other documented work on
the leaves of S. cayennensis [24,23].
Effect on phagocytic activity of polymorphonuclear
leucocytes
Artesunate at the doses tested exhibited non-significant
(p > 0.05) phagocytic stimulation compared to the control
(Figure 1). MESC also at doses tested exhibited no signifi-
cant (p > 0.05) phagocytic stimulation except the 100 μg/ml
dose which exhibited significant (p < 0.05) phagocytic
stimulation compared to the control. Moreover, the com-
bined doses of the MESC and artesunate exhibited sig-
nificant (p < 0.05) phagocytic stimulation (Figure 1). At
100 μg/ml concentration, artesunate, MESC, levamisole
and artesunate plus MESC showed percentage phagocytic
stimulation of 17.75, 139.64, 223.66 and 393.77% respec-
tively (Figure 2). In addition the combined doses of the
MESC and artesunate exhibited the highest phagocytic
index (PI) and percentage phagocytic stimulation com-
pared to the effects of the separate doses, the control and
the levamisole, a standard agent (Figures 1 & 2).
Determination of Delayed Type Hypersensitivity Response
(DTHR)
The MESC at the doses tested showed significant (p < 0.05)






























Figure 1 Phagocytic indexes (PI) of methanol extract of Stachytarpheta cayennensis (MESC), levamisole, artesunate and the combined
effects of MESC and artesunate. PI showed the degree of phagocytic activities of polymorphonuclear leucocytes.
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inhibition of the DTHR of 64.21% greater than that of lev-
amisole which was 58.05% (Table 2).
Determination of humoral immune response
The MESC caused dose dependent statistically signifi-
cant (p < 0.05) elevation in the secondary antibody titres
at the doses treated compared with the control. More-























Figure 2 Percentage of phagocytic stimulation of the Stachytarpheta
combined effects of MESC and artesunate.secondary mean titre values from the primary means
titre values (Table 3).
In vivo leucocytes mobilization test
The result of the in vivo leucocyte mobilization showed
that MESC produced a dose-dependent increase in the
peritoneal percentage leucocyte mobilization up to the
250 mg/kg dose as well as that of the neutrophil dif-






cayennensis extract (MESC), levamisole, artesunate and the
Table 2 The effect MESC on delayed type hypersensitivity reaction
Treatment Dose (mg/kg) Paw thickness (mm) Inhibition of DTHR (%)
MESC 100 0.840 ± 0.07* 55.79
MESC 250 0.770 ± 0.03* 59.47
MESC 500 0.680 ± 0.06* 64.21
Levamisole 2.5 0.797 ± 0.22* 58.05
Control - 1.900 ± 0.07 -
Values are expressed as the mean ± SEM using ANOVA, Dunnet as Post hoc.
*p < 0.05 compared with the control; n = 5.
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analysis while the 250 mg/kg dose exhibited highest per-
centage leucocyte mobilization of 10.15% (Table 4).
Discussion
Findings from this study showed that MESC exhibited
potent immunomodulatory effect on both humoral me-
diated and cell mediated immune responses. On humoral
mediated immune response, MESC enhanced antibody
synthesis whereas it stimulated phagocytic activity of poly-
morphonuclear leucocytes (PMNs) and suppressed the
delayed type hypersensitivity reaction induced by SRBCs
which are all cell-mediated events. It also enhanced
leukocyte migration under inflammatory stimulus.
The increase in antibody titre evoked by MESC clearly
indicates stimulation of the humoral immunity. Humoral-
mediated immunity involves the production specific
antibodies (immunoglobulins) by bursa equivalent lym-
phocytes or plasma cells following sensitization to specific
antigen [34]. Humoral immunity or antibody-mediated
immunity is part of the body’s adaptive immune response
produced by the B-cell lymphocytes responsible for anti-
body production. It is activated by the alpha globulin
antibodies on contact with antigenic substances such as
proteins or polysaccharides foreign to the body. By sti-
mulating antibody production, MESC may augment the
body’s immunity and enhance its capacity to contain in-
fections of both bacterial and viral origins, which are or-
ganisms responsible for body’s immune depletion.
In addition to augmenting the humoral immune






Values are expressed as the mean ± SEM using ANOVA, Dunnet as Post hoc.
*p < 0.05 compared with the control; n = 5.neutrophils which suggests that it may enhance phago-
cytic activity of polymorphonuclear leukocytes and other
phagocytic cells like macrophages. PMNs which can
engulf, kill and digest microorganisms are usually the pri-
mary granulocytes attracted to invading pathogens by che-
motaxins for destruction and elimination of the pathogens
[35]. Phagocytic activity provides another line of defense
against pathogenic invasion and contributes to streng-
thening the body’s immunity.
Besides the phagocytic actions of these cells at sites of
inflammation or microbial invasion, the extent of their
migration is equally important. Fortunately, the effect
of MESC on leukocyte migration also showed it may
enhance cell migration under inflammatory stimulus.
Our results showed that treatment with MESC increased
total and differential cell counts at the sites of injection
of the inflammogen. The import of this action is that
MESC may likely quicken cellular response to inflamma-
tion and microbial invasion in addition to stimulating
and enhancing their immunological mechanisms such as
phagocytosis. These actions clearly indicate immune-
boosting properties of MESC.
The immunomodulatory activity of MESC alone was
comparable to that of levamisole, a standard immuno-
modulatory agent. Levamisole, an immunostimulant, has
the tendency to restore depressed immune function of
the B-lymphocytes, T-lymphocytes, monocytes and mac-
rophages [35]. The combined treatment of artesunate, a
derivative of artemisinin with immunomodulatory effects
[17], and MESC exhibited enhanced immunomodulatory
activity on phagocytic activity of PMNs. The enhancedal immune response
Primary (mean titre) Secondary (mean titre)
2.83 ± 0.17 3.00 ± 0.00
3.38 ± 0.43 3.52 ± 0.87*
3.75 ± 0.25 4.25 ± 0.87*
3.75 ± 0.25 2.30 ± 0.45
Table 4 The effect of MESC on in-vivo Leucocytes mobilization
Treatment Dose (mg/kg) TLC (cell mm-3) Leucocytes mobilization (%) Differentials
Neutrophil Lymphocytes
MESC 100 46.50 ± 4.99 -5.58 0.75 ± 0.16 44.80 ± 4.69
MESC 250 54.25 ± 18.20 10.15 4.49 ± 1.84 29.67 ± 11.97
MESC 500 50.25 ± 6.57 2.03 3.79 ± 1.38 46.54 ± 5.56
Control - 49.25 ± 6.10 - 4.15 ± 0.78 45.11 ± 6.67
Values are expressed as the mean ± SEM using ANOVA, Dunnet as Post hoc, n = 5.
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MESC combination could be due to increased phago-
cytosis by the PMNs (neutrophils) exhibited by both
agents. The PMNs being the first of the blood leucocytes
to enter an inflamed cellular area can exhibit appre-
ciable modulation of pro-inflammatory cytokines such as
TNF-α, IL-1 and IL-10. Modulation of cytokines by arte-
sunate could be a possible mechanism of its immuno-
modulatory actions since previous studies have reported
the immunomodulatory effects of artesunate on cytokine
production [36,17]. Although the scope of this study
may not permit elucidation of the specific mechanisms
associated with the actions of MESC on humoral and
cell-mediated immunity, augmentation or modulation of
the immune system is supposedly mediated through
opsonization, direct neutralization of antigen, agglut-
ination of antigen and activation of complement system
to cause lyses and death of antigenic cells [37]. Additio-
nally, the leaf extract of S. cayennensis has been reported
to possess antimalarial activity [19], it therefore, implies
that the combined effect of MESC and artesunate may
not only stimulate immune system, but also offer a good
synergistic effect in the eradication of malaria parasites,
thus proffering a possible new usage. In sub-Saharan
Africa where there is high prevalence of malarial scourge,
this combination will be a good therapeutic advantage
especially to rural dwellers.
Studies on DTHR showed that MESC suppressed
DTHR in treated animals. DTHR is a feature of chronic
inflammation. In chronic inflammatory conditions such
as rheumatoid arthritis, there is usually the manifes-
tation of delayed hypersensitivity in the cells [38]. DTHR
is a T-cell mediated event and the extent to which
MESC or its constituents interferes with such reactions
is not clear to us. The inhibitory and suppressive actions
of MESC on DTHR induced by SRBCs could arise from
mechanisms associated with its anti-inflammatory effect
and may contribute to the usefulness of this plant in
disorders of chronic inflammation such as arthritis and
other musculoskeletal pains [18,20]. Elsewhere, artesu-
nate and other artemisinin derivatives have been shown
to markedly suppress DTHR on chronic administration
in laboratory animals [17].The results of qualitative phytochemical analysis revealed
the presence of carbohydrates, glycosides, flavonoids, sa-
ponins, alkaloids, terpenoids and steroids. Although no
constituents could be linked to the immunomodulatory
properties of the plant at this stage, studies have shown
that different types of flavonoids may stimulate human
peripheral blood leukocyte proliferation [39,40]. Fla-
vonoids have reported to cause increase in the helper
T cells, interleukin 2 (IL-2), interferon and macro-
phages; hence they are useful in several diseases of im-
mune dysfunction [41-43].
Acute toxicity studies of MESC showed an estimated
LD50 greater than 5000 mg/kg, which is an indication of
relative safety and remote risk of acute intoxication.
Conclusion
In conclusion, this study showed that the leaves of
S. cayennensis exhibited potent immunomodulatory prop-
erties. Combination of the extract with artesunate showed
synergistic immunomodulatory effect, and could offer ad-
ditional benefit in malaria treatment.
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